EPA:ICAD - Euronext Paris - Matif - FR0000035081 - REIT - Currency: EUR
EPA:ICAD (6/20/2025, 7:00:00 PM)
23.24
+0.16 (+0.69%)
The current stock price of ICAD.PA is 23.24 EUR. In the past month the price increased by 1.31%. In the past year, price decreased by -4.68%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MRL.LS | MERLIN PROPERTIES SOCIMI SA | 19.16 | 6.16B | ||
COV.PA | COVIVIO | 11.5 | 5.74B | ||
NEXTA.BR | NEXTENSA | N/A | 431.21M | ||
PAT.PA | PATRIMOINE ET COMMERCE-REGR | 9.05 | 381.68M | ||
IMDA.PA | IMMOBILIERE DASSAULT SA | 13.28 | 363.58M | ||
ATLD.PA | ATLAND | 22.12 | 200.25M | ||
WEB.BR | WAREHOUSES ESTATES BELGIUM | 11.34 | 124.60M | ||
CBSM.PA | SCBSM | 300 | 123.57M | ||
PAR.PA | PAREF | N/A | 61.86M | ||
DIEG.BR | DIEGEM KENNEDYCERT | N/A | 11.50M |
Icade SA operates as a real estate and commercial property investment company, which engages in the investment, development, and provision of services to the public and private properties. The company is headquartered in Issy-Les-Moulineaux, Ile-De-France and currently employs 1,006 full-time employees. Its activities are organized around Offices, Business Parks, Healthcare, Shopping Centres, Warehouses and Public Sector Investment. The Offices division holds and manages office buildings. The Business Parks division is taking care for the business campus created in Paris, combining diverse activities across a range of sectors. The Healthcare business invests in clinic buildings; the Shopping Centres holds two big shopping centres combining shopping and leisure. The firm also rents the space in its warehouses, invests in buildings outsourced by the government and leases them to public sector users such as government departments and local authorities. The main shareholder of the Company is Credit Agricole Assurances. The company operates through Arkadea and ANF Immobilier SA.
ICADE
Open, 27 rue Camille Desmoulins
Issy-les-Moulineaux ILE-DE-FRANCE FR
Employees: 1006
Phone: 33141577000
The current stock price of ICAD.PA is 23.24 EUR. The price increased by 0.69% in the last trading session.
The exchange symbol of ICADE is ICAD and it is listed on the Euronext Paris - Matif exchange.
ICAD.PA stock is listed on the Euronext Paris - Matif exchange.
20 analysts have analysed ICAD.PA and the average price target is 25.92 EUR. This implies a price increase of 11.51% is expected in the next year compared to the current price of 23.24. Check the ICADE stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ICADE (ICAD.PA) has a market capitalization of 1.77B EUR. This makes ICAD.PA a Small Cap stock.
ICADE (ICAD.PA) currently has 1006 employees.
ICADE (ICAD.PA) has a support level at 23.23 and a resistance level at 23.7. Check the full technical report for a detailed analysis of ICAD.PA support and resistance levels.
The Revenue of ICADE (ICAD.PA) is expected to decline by -8.73% in the next year. Check the estimates tab for more information on the ICAD.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ICADE (ICAD.PA) has a dividend yield of 5.03%. The yearly dividend amount is currently 4.84. Check the full fundamental report for a detailed analysis of ICAD.PA dividend history, reliability and sustainability.
ICADE (ICAD.PA) will report earnings on 2025-07-23.
The PE ratio for ICADE (ICAD.PA) is 7.35. This is based on the reported non-GAAP earnings per share of 3.16 and the current share price of 23.24 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ICAD.PA.
ChartMill assigns a technical rating of 7 / 10 to ICAD.PA. When comparing the yearly performance of all stocks, ICAD.PA turns out to be only a medium performer in the overall market: it outperformed 66.26% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to ICAD.PA. ICAD.PA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months ICAD.PA reported a non-GAAP Earnings per Share(EPS) of 3.16. The EPS increased by 12.06% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -2.62% | ||
ROE | -6.38% | ||
Debt/Equity | 0.99 |
ChartMill assigns a Buy % Consensus number of 71% to ICAD.PA. The Buy consensus is the average rating of analysts ratings from 20 analysts.
For the next year, analysts expect an EPS growth of 7.14% and a revenue growth -8.73% for ICAD.PA